Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial

DSpace Repository

Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial

Author: Goeke, Burkhard; Gallwitz, Baptist; Eriksson, Johan G.; Hellqvist, Asa; Gause-Nilsson, Ingrid
Tübinger Autor(en):
Gallwitz, Baptist
Published in: International Journal of Clinical Practice (2013), Bd. 67, H. 4, S. 307-316
Verlagsangabe: Wiley - Blackwell
Language: English
Full text: http://dx.doi.org/10.1111/ijcp.12119
ISSN: 1368-5031
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)